Cargando…
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease (COVID-19) pandemic which is characterized by respiratory illness and severe pneumonia, and currently accounts for > 2.5 million deaths worldwide. Recently, diverse mutations in the spi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357147/ https://www.ncbi.nlm.nih.gov/pubmed/34379620 http://dx.doi.org/10.1371/journal.pone.0253574 |
_version_ | 1783737083594014720 |
---|---|
author | Rattanapisit, Kaewta Bulaon, Christine Joy I. Khorattanakulchai, Narach Shanmugaraj, Balamurugan Wangkanont, Kittikhun Phoolcharoen, Waranyoo |
author_facet | Rattanapisit, Kaewta Bulaon, Christine Joy I. Khorattanakulchai, Narach Shanmugaraj, Balamurugan Wangkanont, Kittikhun Phoolcharoen, Waranyoo |
author_sort | Rattanapisit, Kaewta |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease (COVID-19) pandemic which is characterized by respiratory illness and severe pneumonia, and currently accounts for > 2.5 million deaths worldwide. Recently, diverse mutations in the spike protein of SARS-CoV-2 were reported in United Kingdom (Alpha) and South Africa (Beta) strains which raise concerns over the potential increase in binding affinity towards the host cell receptor and diminished host neutralization capabilities. In order to study the effect of mutation in the binding efficiency of SARS-CoV-2 receptor binding domain (RBD) with anti-SARS-CoV/CoV-2 monoclonal antibodies (mAbs), we have produced SARS-CoV-2 RBD and two variants SARS-CoV-2 RBD (Alpha RBD and Beta RBD) in Nicotiana benthamiana by transient expression. Plant-produced SARS-CoV-2 RBD-Fc, Alpha RBD-Fc and Beta RBD-Fc exhibited specific binding to human angiotensin converting enzyme 2 (ACE2) receptor determined by ELISA. Intriguingly, the binding of plant-produced SARS-CoV-2 RBD proteins to plant-produced mAbs CR3022, B38, and H4 was found to be different depending on the variant mutation. In contrary to the plant-produced SARS-CoV-2 RBD-Fc and Alpha RBD-Fc, Beta RBD-Fc variant showed weak binding affinity towards the mAbs. The result suggested that the Beta RBD variant might have acquired partial resistance to neutralizing antibodies compared to other variants. However, further studies with sera from convalescent or vaccinated individuals are required to confirm this finding. |
format | Online Article Text |
id | pubmed-8357147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-83571472021-08-12 Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies Rattanapisit, Kaewta Bulaon, Christine Joy I. Khorattanakulchai, Narach Shanmugaraj, Balamurugan Wangkanont, Kittikhun Phoolcharoen, Waranyoo PLoS One Research Article Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease (COVID-19) pandemic which is characterized by respiratory illness and severe pneumonia, and currently accounts for > 2.5 million deaths worldwide. Recently, diverse mutations in the spike protein of SARS-CoV-2 were reported in United Kingdom (Alpha) and South Africa (Beta) strains which raise concerns over the potential increase in binding affinity towards the host cell receptor and diminished host neutralization capabilities. In order to study the effect of mutation in the binding efficiency of SARS-CoV-2 receptor binding domain (RBD) with anti-SARS-CoV/CoV-2 monoclonal antibodies (mAbs), we have produced SARS-CoV-2 RBD and two variants SARS-CoV-2 RBD (Alpha RBD and Beta RBD) in Nicotiana benthamiana by transient expression. Plant-produced SARS-CoV-2 RBD-Fc, Alpha RBD-Fc and Beta RBD-Fc exhibited specific binding to human angiotensin converting enzyme 2 (ACE2) receptor determined by ELISA. Intriguingly, the binding of plant-produced SARS-CoV-2 RBD proteins to plant-produced mAbs CR3022, B38, and H4 was found to be different depending on the variant mutation. In contrary to the plant-produced SARS-CoV-2 RBD-Fc and Alpha RBD-Fc, Beta RBD-Fc variant showed weak binding affinity towards the mAbs. The result suggested that the Beta RBD variant might have acquired partial resistance to neutralizing antibodies compared to other variants. However, further studies with sera from convalescent or vaccinated individuals are required to confirm this finding. Public Library of Science 2021-08-11 /pmc/articles/PMC8357147/ /pubmed/34379620 http://dx.doi.org/10.1371/journal.pone.0253574 Text en © 2021 Rattanapisit et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rattanapisit, Kaewta Bulaon, Christine Joy I. Khorattanakulchai, Narach Shanmugaraj, Balamurugan Wangkanont, Kittikhun Phoolcharoen, Waranyoo Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title | Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title_full | Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title_fullStr | Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title_full_unstemmed | Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title_short | Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
title_sort | plant-produced sars-cov-2 receptor binding domain (rbd) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357147/ https://www.ncbi.nlm.nih.gov/pubmed/34379620 http://dx.doi.org/10.1371/journal.pone.0253574 |
work_keys_str_mv | AT rattanapisitkaewta plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies AT bulaonchristinejoyi plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies AT khorattanakulchainarach plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies AT shanmugarajbalamurugan plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies AT wangkanontkittikhun plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies AT phoolcharoenwaranyoo plantproducedsarscov2receptorbindingdomainrbdvariantsshoweddifferentialbindingefficiencywithantispikespecificmonoclonalantibodies |